These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 3022608

  • 21. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Ajayi AA, Hockings N, Reid JL.
    Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047
    [Abstract] [Full Text] [Related]

  • 22. Comparison of different drug interference with the renin-angiotensin system.
    Hofbauer KG, Fuhrer W, Heusser C, Wood JM.
    J Cardiovasc Pharmacol; 1985 Apr; 7 Suppl 4():S62-8. PubMed ID: 2412016
    [Abstract] [Full Text] [Related]

  • 23. Effect of left atrial to left femoral artery bypass and renin-angiotensin system blockade on renal blood flow and function during and after thoracic aortic occlusion.
    Joob AW, Dunn C, Miller E, Freedlender A, Kron IL.
    J Vasc Surg; 1987 Feb; 5(2):329-35. PubMed ID: 3029438
    [Abstract] [Full Text] [Related]

  • 24. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
    Van Guilder GP, Pretorius M, Luther JM, Byrd JB, Hill K, Gainer JV, Brown NJ.
    Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
    [Abstract] [Full Text] [Related]

  • 25. Brachial artery hemodynamic response to acute converting enzyme inhibition by enalaprilat in essential hypertension.
    Simon AC, Chau NP, Levenson J.
    Clin Pharmacol Ther; 1988 Jan; 43(1):49-54. PubMed ID: 2826067
    [Abstract] [Full Text] [Related]

  • 26. Responses to renin inhibition in conscious primates.
    Humke U, Levens N, Wood J, Hofbauer K.
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F179-86. PubMed ID: 1907105
    [Abstract] [Full Text] [Related]

  • 27. Control of arterial pressure and renal function during chronic renin inhibition.
    Hall JE, Mizelle HL.
    J Hypertens; 1990 Apr; 8(4):351-9. PubMed ID: 2160492
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of renin in the primate Callithrix jacchus (common marmoset).
    Hofbauer KG, Ménard J, Michel JB, Wood JM.
    Clin Exp Hypertens A; 1983 Apr; 5(7-8):1237-47. PubMed ID: 6196144
    [Abstract] [Full Text] [Related]

  • 29. Endogenous prostaglandins modulate autoregulation of renal blood flow in young rats.
    Chevalier RL, Carey RM, Kaiser DL.
    Am J Physiol; 1987 Jul; 253(1 Pt 2):F66-75. PubMed ID: 3037924
    [Abstract] [Full Text] [Related]

  • 30. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH, Cody RJ.
    Clin Pharmacokinet; 1985 Jul; 10(5):377-91. PubMed ID: 2994938
    [Abstract] [Full Text] [Related]

  • 31. Effects of acute angiotensin converting enzyme inhibition on renal blood flow in patients with stable congestive heart failure.
    Le Jemtel TH, Maskin CS, Chadwick B.
    Am J Med Sci; 1986 Sep; 292(3):123-7. PubMed ID: 3019136
    [Abstract] [Full Text] [Related]

  • 32. Dilation of epicardial arteries in conscious dogs induced by angiotensin-converting enzyme inhibition with enalaprilat.
    Holtz J, Busse R, Sommer O, Bassenge E.
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):348-55. PubMed ID: 2437401
    [Abstract] [Full Text] [Related]

  • 33. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
    Sweet CS, Ludden CT, Frederick CM, Bush LR, Ribeiro LG.
    J Cardiovasc Pharmacol; 1984 Mar; 6(6):1067-75. PubMed ID: 6084762
    [Abstract] [Full Text] [Related]

  • 34. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP, Lal SM, Whalen JJ, Bauer JH.
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [Abstract] [Full Text] [Related]

  • 35. Two-kidney, one clip renal hypertension in the marmoset.
    Wood JM, Gulati N, Michel JB, Hofbauer KG.
    J Hypertens; 1986 Apr; 4(2):251-4. PubMed ID: 3011892
    [Abstract] [Full Text] [Related]

  • 36. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J, Rabinowe S, Hollenberg NK, Williams GH.
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [Abstract] [Full Text] [Related]

  • 37. Coronary vasodilation induced by intracoronary enalaprilat: an argument for the role of a local renin-angiotensin system in patients with dilated cardiomyopathy.
    Foult JM, Tavolaro O, Antony I, Nitenberg A.
    Eur Heart J; 1989 Nov; 10 Suppl F():97-100. PubMed ID: 2559850
    [Abstract] [Full Text] [Related]

  • 38. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M, Shalmi M, Petersen JS, Poulsen LB, Christensen S.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [Abstract] [Full Text] [Related]

  • 39. Antihypertensive action of angiotensin-I converting enzyme inhibitors in the kidney.
    Matsukawa S, Suzuki H, Itaya Y, Kumagai H, Saruta T.
    Clin Exp Hypertens A; 1987 Jul; 9(2-3):391-4. PubMed ID: 3038401
    [Abstract] [Full Text] [Related]

  • 40. Biochemical effects of prolonged renin inhibition in marmosets.
    Wood JM, Jobber RA, Baum HP, de Gasparo M, Nussberger J.
    J Hypertens; 1989 Aug; 7(8):615-8. PubMed ID: 2681408
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.